Lucentis 50242-0080-03

Generic: Ranibizumab

Package NDC

50242-0080-03

Manufacturer: Genentech, Inc.
Dosage Form: Injection, Solution
Route: Intravitreal
Product Type: Human Prescription Drug
Marketing Start: June 30, 2006
Listing Expires: December 31, 2026
Application: BLA125156

Need to source Lucentis? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ranibizumab	10 mg/mL

Drug Class

Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]

Selected Package

50242-0080-03Selected

1 SYRINGE, GLASS in 1 CARTON (50242-080-03) / .05 mL in 1 SYRINGE, GLASS

Other packages for this product(1)

50242-0080-88

1 SYRINGE, GLASS in 1 CARTON (50242-080-88) / .05 mL in 1 SYRINGE, GLASS

View →